Innoviva Inc (INVA) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Innoviva Inc

NASDAQ | INVA

18.27

USD

+0.18 (+1.00%)

AT CLOSE (AS OF Apr 17, 2025)

$1.1B

MARKET CAP

50.75

P/E Ratio

0.36

EPS

$21

52 Week High

$15

52 Week Low

LIFE SCIENCES

Sector

INVA Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

INVA Technicals

Tags:

INVA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$359M
Total Revenue	$359M
Cost Of Revenue	$37M
Costof Goods And Services Sold	$37M
Operating Income	$229M
Selling General And Administrative	$116M
Research And Development	$14M
Operating Expenses	$129M
Investment Income Net	-
Net Interest Income	-$3.1M
Interest Income	$19M
Interest Expense	$22M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$26M
Income Before Tax	$37M
Income Tax Expense	$14M
Interest And Debt Expense	-
Net Income From Continuing Operations	$23M
Comprehensive Income Net Of Tax	-
Ebit	$60M
Ebitda	$85M
Net Income	$23M

Revenue & Profitability

Earnings Performance

INVA Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$1.3B
Total Current Assets	$554M
Cash And Cash Equivalents At Carrying Value	$305M
Cash And Short Term Investments	$305M
Inventory	$34M
Current Net Receivables	-
Total Non Current Assets	$747M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$208M
Intangible Assets Excluding Goodwill	$208M
Goodwill	$18M
Investments	-
Long Term Investments	$394M
Short Term Investments	$108M
Other Current Assets	$195M
Other Non Current Assets	-
Total Liabilities	$610M
Total Current Liabilities	$236M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$194M
Total Non Current Liabilities	$374M
Capital Lease Obligations	$2.8M
Long Term Debt	$256M
Current Long Term Debt	$192M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$192M
Other Current Liabilities	-$14M
Other Non Current Liabilities	-
Total Shareholder Equity	$691M
Treasury Stock	-
Retained Earnings	-$1.8M
Common Stock	$627K
Common Stock Shares Outstanding	$74M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	$189M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$40M
Capital Expenditures	$270K
Change In Receivables	-
Change In Inventory	$14M
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$13M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$15M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$23M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$359M
Total Revenue	$359M
Cost Of Revenue	$37M
Costof Goods And Services Sold	$37M
Operating Income	$229M
Selling General And Administrative	$116M
Research And Development	$14M
Operating Expenses	$129M
Investment Income Net	-
Net Interest Income	-$3.1M
Interest Income	$19M
Interest Expense	$22M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$26M
Income Before Tax	$37M
Income Tax Expense	$14M
Interest And Debt Expense	-
Net Income From Continuing Operations	$23M
Comprehensive Income Net Of Tax	-
Ebit	$60M
Ebitda	$85M
Net Income	$23M

Dividends

Field	Value
Ex Dividend Date	2015-09-08
Declaration Date	None
Record Date	None
Payment Date	None
Amount	0.25

INVA News

INVA Profile

Innoviva Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.00	9.68%	-	409,386,220
STSS	$0.03	20.75%	$522.68K	391,799,240
NVDA	$101.49	-2.87%	$2.48T	292,517,465
HTZ	$8.24	44.31%	$2.54B	266,908,117
FMTO	$0.02	-35.81%	$2.41M	198,396,141

Symbol	Price	Change %	Market Cap	Volume
LLY	$839.96	14.30%	$754.27B	10,853,385
PG	$170.63	2.55%	$400.10B	7,227,061
JNJ	$157.47	2.31%	$379.48B	10,981,067
ABBV	$172.99	0.76%	$306.02B	8,998,056
NVO	$58.08	-7.63%	$282.79B	32,220,629

Symbol	Price	Change %	Market Cap	Volume
MSGM	$2.75	145.54%	$8.75M	36,058,545
SXTC	$2.16	118.42%	$29.73M	51,508,885
ADGM	$1.78	92.81%	$54.65M	114,733,769
PNBK	$3.28	73.55%	$13.04M	1,511,087
RTC	$0.37	72.09%	$10.86M	187,018,434

Symbol	Price	Change %	Market Cap	Volume
JEWL	$0.00	-90.83%	$2.78M	470,134
LXEH	$6.84	-70.25%	$26.82M	1,373,607
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644

Quick Links

INVA $18.27 (+1.00%) Quote details